CARGO Therapeutics Inc

NASDAQ: CRGX
$19.09
+$0.09 (+0.5%)
Closing price May 10, 2024

CRGX Chart and Intraday Price

CRGX Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 1900 ALAMEDA LAS PULGAS, SUITE 350, SAN MATEO, CA, UNITED STATES
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 941.12M USD
Shares Outstanding 41,205,100
CARGO Therapeutics Inc is a trailblazer in the biotechnology sector, focusing on developing advanced treatments for cancer through chimeric antigen receptor (CAR) T-cell therapies. Its flagship project, CRG-022, aims to combat B-cell malignancies by targeting CD22, a crucial tumor antigen. Additionally, the company is working on CRG-023, a pioneering tri-specific CAR T therapy that targets three B-cell antigens simultaneously. Founded in 2019 and based in San Mateo, California, CARGO Therapeutics is dedicated to revolutionizing cancer treatment.

CRGX Articles

Insiders Are Loading Up on These Biotech and Energy Stocks
Notable insider buying in the past week included biotech and energy companies, including some that have just gone public. Also, renowned hedge fund manager Bill Ackman continues building a stake in a...
Trey Thoelcke
Published: